ClinicalTrials.Veeva

Menu

Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France (TSAR)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

Tuberous Sclerosis Complex

Study type

Observational

Funder types

Other

Identifiers

NCT02887781
TSAR (RB 14.055)

Details and patient eligibility

About

This study aims to investigate the factors (clinical, care-related and genetic) affecting renal outcome in patients with TSC (Tuberous sclerosis complex)

Enrollment

150 estimated patients

Sex

All

Ages

8+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria of study participants

  • Patient presenting with an isolated angiomyolipoma or
  • Patient presenting with tuberous sclerosis complex combined with an angiomyolipoma or
  • Patient presenting with tuberous sclerosis complex
  • Patient not objecting to the study

Exclusion criteria of study participants

■Patient objecting to the study

Trial contacts and locations

2

Loading...

Central trial contact

Yannick LE MEUR, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems